ORAGENICS INC (OGEN) › Cash & EquivalentsORAGENICS INC (OGEN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $301.6K2010: $132.1K2011: $171.7K2012: $9.93M2013: $16.28M2014: $10.45M2015: $5.08M2016: $4.08M2017: $6.17M2018: $20.21M2019: $18.27M2020: $17.64M2021: $27.27M2022: $11.43M2023: $3.48M2024: $864.8K2025: $4.40M$4.40M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$4.40M+408.7%2024$864.8K-75.2%2023$3.48M-69.5%2022$11.43M-58.1%2021$27.27M+54.6%2020$17.64M-3.4%2019$18.27M-9.6%2018$20.21M+227.7%2017$6.17M+51.1%2016$4.08M-19.7%2015$5.08M-51.4%2014$10.45M-35.8%2013$16.28M+64.0%2012$9.93M+5679.7%2011$171.7K+30.0%2010$132.1K-56.2%2009$301.6K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share